GB1386656A - Adenosine-5-carboxylic acid amides - Google Patents
Adenosine-5-carboxylic acid amidesInfo
- Publication number
- GB1386656A GB1386656A GB844672A GB844672A GB1386656A GB 1386656 A GB1386656 A GB 1386656A GB 844672 A GB844672 A GB 844672A GB 844672 A GB844672 A GB 844672A GB 1386656 A GB1386656 A GB 1386656A
- Authority
- GB
- United Kingdom
- Prior art keywords
- adenosine
- carboxylic acid
- compounds
- acid amides
- prepared
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/06—Pyrimidine radicals
Abstract
1386656 Adenosine-5<SP>1</SP>-carboxylic acid amides ABBOT LABORATORIES 23 Feb 1972 [18 March 1971] 8446/72 Heading C2C Novel compounds of general Formula I in which R is NHR 1 or NR 1 R 2 and R 1 and R 2 are selected from C 1-6 haloalkyl, C 3-6 hydroxyalkyl (C 3-7 cycloalkyl) C 1-6 alkyl, C 2-6 haloalkenyl, C 2-6 alkynyl, C 2-6 haloalkynyl or alkoxyalkyl with up to 6 C atoms are prepared by converting adenosine-5<SP>1</SP>-carboxylic acid (prepared from 2<SP>1</SP>,3<SP>1</SP>-isopropylidene adenosine) to the corresponding acid chloride by using thionyl chloride and reacting the acid chloride with ammonia or an appropriately substituted alkylamine. Compounds referred to are those in which the amide group is N-cyclopropylmethyl amido, N-propargylamido, N-ethoxyethylamido, N,N-dicyclopropylmethylamide and N,N-di-chloromethylamido. Compounds of Formula I are anti-hypertensive and anti-anginal agents and form with a carrier a pharmaceutical composition which may be administered orally or parenterally. Reference has been directed by the Comptroller to Specification 1,295,228.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US12589371A | 1971-03-18 | 1971-03-18 |
Publications (1)
Publication Number | Publication Date |
---|---|
GB1386656A true GB1386656A (en) | 1975-03-12 |
Family
ID=22421948
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB844672A Expired GB1386656A (en) | 1971-03-18 | 1972-02-23 | Adenosine-5-carboxylic acid amides |
Country Status (9)
Country | Link |
---|---|
AU (1) | AU466714B2 (en) |
CA (1) | CA1019727A (en) |
CH (1) | CH551446A (en) |
DE (1) | DE2213180A1 (en) |
FR (1) | FR2130364A1 (en) |
GB (1) | GB1386656A (en) |
PH (1) | PH9469A (en) |
SE (1) | SE405363B (en) |
ZA (1) | ZA721222B (en) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6495528B1 (en) | 1998-06-23 | 2002-12-17 | Smithkline Beecham Corporation | 2-(Purin -9-yl)-tetrahydrofuran-3,4-diol derivatives |
US6762170B1 (en) | 1998-01-31 | 2004-07-13 | Smithklinebeecham Corporation | 2-(purin-9-yl)-tetrahydrofuran-3,4-diol derivatives |
US7737126B2 (en) | 2004-05-24 | 2010-06-15 | Glaxo Group Limited | Purine derivative |
US7985740B2 (en) | 2005-07-19 | 2011-07-26 | Glaxo Group Limited | Purine derivatives as agonists of the adenosine A2A receptor |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FI880405A (en) * | 1987-02-04 | 1988-08-05 | Ciba Geigy Ag | Adenosine-5'-KARBOXAMIDDERIVAT. |
TW528755B (en) | 1996-12-24 | 2003-04-21 | Glaxo Group Ltd | 2-(purin-9-yl)-tetrahydrofuran-3,4-diol derivatives |
US6534651B2 (en) | 2000-04-06 | 2003-03-18 | Inotek Pharmaceuticals Corp. | 7-Substituted isoindolinone inhibitors of inflammation and reperfusion injury and methods of use thereof |
US8101209B2 (en) | 2001-10-09 | 2012-01-24 | Flamel Technologies | Microparticulate oral galenical form for the delayed and controlled release of pharmaceutical active principles |
PT1492511E (en) | 2002-04-09 | 2009-04-09 | Flamel Tech Sa | Oral pharmaceutical formulation in the form of aqueous suspension for modified release of active principle(s) |
WO2003084517A2 (en) | 2002-04-09 | 2003-10-16 | Flamel Technologies | Oral suspension of amoxicillin capsules |
-
1972
- 1972-02-22 CA CA135,283A patent/CA1019727A/en not_active Expired
- 1972-02-23 GB GB844672A patent/GB1386656A/en not_active Expired
- 1972-02-24 AU AU39346/72A patent/AU466714B2/en not_active Expired
- 1972-02-24 ZA ZA721222A patent/ZA721222B/en unknown
- 1972-03-15 PH PH13354*UA patent/PH9469A/en unknown
- 1972-03-16 CH CH387372A patent/CH551446A/en not_active IP Right Cessation
- 1972-03-17 SE SE7203515A patent/SE405363B/en unknown
- 1972-03-17 DE DE19722213180 patent/DE2213180A1/en active Pending
- 1972-03-17 FR FR7209349A patent/FR2130364A1/fr not_active Withdrawn
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6762170B1 (en) | 1998-01-31 | 2004-07-13 | Smithklinebeecham Corporation | 2-(purin-9-yl)-tetrahydrofuran-3,4-diol derivatives |
US6495528B1 (en) | 1998-06-23 | 2002-12-17 | Smithkline Beecham Corporation | 2-(Purin -9-yl)-tetrahydrofuran-3,4-diol derivatives |
US7737126B2 (en) | 2004-05-24 | 2010-06-15 | Glaxo Group Limited | Purine derivative |
US7985740B2 (en) | 2005-07-19 | 2011-07-26 | Glaxo Group Limited | Purine derivatives as agonists of the adenosine A2A receptor |
Also Published As
Publication number | Publication date |
---|---|
AU3934672A (en) | 1973-08-30 |
FR2130364A1 (en) | 1972-11-03 |
PH9469A (en) | 1975-12-16 |
AU466714B2 (en) | 1973-08-30 |
DE2213180A1 (en) | 1972-09-28 |
SE405363B (en) | 1978-12-04 |
ZA721222B (en) | 1972-11-29 |
CA1019727A (en) | 1977-10-25 |
CH551446A (en) | 1974-07-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB1379230A (en) | Photopolymerizable compounds | |
GB1386656A (en) | Adenosine-5-carboxylic acid amides | |
ES315990A1 (en) | Adamant-1-yl-and homoadamant-1-yl-oxy-, -thio-and amino guanidine derivatives | |
ES8101073A1 (en) | (Ergolin-yl)-N', N'-diethyl urea derivatives, their preparation and pharmaceutical compositions containing them. | |
ES8200353A1 (en) | Tetrazolyloxycarbon amides, process for their preparation and their use as herbicides. | |
GB1346428A (en) | Emulsifier compositions | |
GB1346625A (en) | Synthesis of lactams | |
GB937723A (en) | Pyrazolo-pyrimidines and process for their manufacture | |
GB1274809A (en) | Evomonoside derivatives | |
ES438283A1 (en) | Crystalline adducts of carbamoyl sulphoxides and urea in a 1:3 ratio | |
ES472263A1 (en) | Urea derivatives to treat anxiety and aggressivity | |
ES482591A1 (en) | N-Arylsulfonyl pyrroles, their preparation and medicaments containing them. | |
GB1305725A (en) | ||
GB1463945A (en) | Substituted amidine compounds | |
GB1231959A (en) | ||
GB872879A (en) | Electrolytic copper-plating baths | |
GB1292556A (en) | Sulfonamides and their acylates | |
ES311285A1 (en) | í -1,2,4-triazolone-(5) derivatives | |
GB1184076A (en) | Substituted Phenyl Acetic Acid Amides and Process for their Manufacture | |
GB1154914A (en) | Anti-Inflammatory Compositions and methods | |
GB1074468A (en) | Carbalkoxyhtdrazones of the androstane adn estrane series | |
GB1466047A (en) | Substituted amidine compounds | |
GB1040049A (en) | Preparation of tertiary octylguanidines | |
GB1281215A (en) | Improvements relating to the preparation of aza-tricyclo-undecane derivatives | |
GB1339244A (en) | N-1,1 substituted acetonitrilo-a-3,5-substituted phenoxy alkyl amides and their use as herbicides |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PS | Patent sealed | ||
PCNP | Patent ceased through non-payment of renewal fee |